Serum Institute, other firms eye tie-ups to develop monkeypox vaccine

Indian Immunologicals, and Haffkine Research Institute also in the fray

Serum Institute of India (SII) and some other firms have started evaluating options to tie up with international players to develop a monkeypox vaccine. Some of them have shown interest in partnering with the Indian Council of Medical Research (ICMR) to develop the vaccine candidate.

SII CEO Adar Poonawalla had told Business Standard that it was collaborating with Greenlight Biosciences, a US-based company with technology, to make mRNA vaccines, for a handful of vaccines, including one for shingles. “We are even looking at doing something on monkeypox with them. It is a technology that still needs some time,” Poonawalla said.